Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products (PDMPs) Across Europe

Against the backdrop of ongoing EU-level initiatives to improve the availability of critical medicines and strengthen supply chain resilience, this study aimed to map the overall PDMP policy landscape and key access dimensions, including reimbursement coverage, cost-containment measures, and stockpiling policies across Europe.